Asianet Newsable on MSN
REPL stock tracks best day ever: This analyst sees higher approval odds for Replimune’s melanoma after ‘overwhelmingly positive’ panel outcome
Cantor Fitzgerald said the positive panel outcome materially improves the chances of accelerated approval for Replimune's RP1 ...
Shares of Replimune Group Inc (REPL) closed 38% lower on Tuesday, clocking its worst day since early April, after the U.S.
No matter whether you are a seasoned programmer or you simply want to take your first steps in writing code, Repl.it wants to help you get from idea to result as fast as possible — without complicated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results